<DOC>
	<DOCNO>NCT01682681</DOCNO>
	<brief_summary>The purpose study evaluate long-term retention rate topiramate participant epilepsy ( seizure disorder ) .</brief_summary>
	<brief_title>An Observational Study Evaluate Long-term Retention Rate Topiramate Participants With Epilepsy</brief_title>
	<detailed_description>This open-label ( medical research study participant researcher tell treatment participant receive , `` unblinded '' ) , single-arm , prospective ( study follow participant forward time ) , observational ( clinical study participant identify belong study group assess biomedical health outcome ) multi-center ( one hospital medical school team work medical research study ) study topiramte participant epilesy . The study population epilepsy participant visit outpatient study center period two month . Topiramate administer per Investigator 's discretion 52 week . Participants visit trial site evaluation endpoint Baseline , Week 12 , Week 26 , Week 52 . Efficacy primarily evaluate percentage participant retain topiramate treatment uptil Week 52 . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Participants type epilepsy Participants 2 episode seizure last 1 year Participants comply visit schedule willing able complete evaluation procedure specify protocol treatment period Female participant child bear potential use proper contraceptive method study period Participants know hypersensitivity reaction allergy study drug Participants take topiramate within three month study start Participants determine suitable clinical study participation Investigator 's discretion Pregnant nursing female participant</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Topmax</keyword>
</DOC>